ProfileGDS4132 / 230333_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 48% 61% 67% 71% 55% 59% 63% 65% 66% 66% 63% 69% 64% 70% 72% 64% 66% 82% 73% 63% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101129.90748
GSM201543Muscle PCOS pioglitazone 121163.7561
GSM201544Muscle PCOS pioglitazone 161198.35367
GSM201545Muscle PCOS pioglitazone 201231.50671
GSM201829Muscle PCOS pioglitazone 231157.79455
GSM201830Muscle PCOS pioglitazon 251169.27459
GSM201831Muscle PCOS pioglitazone 271183.52463
GSM201832Muscle PCOS pioglitazone 31180.43465
GSM201833Muscle PCOS pioglitazone 41178.84466
GSM201834Muscle PCOS pioglitazone 81190.85866
GSM201835Muscle PCOS after pioglitazone 102170.40263
GSM201836Muscle PCOS after pioglitazone 122198.67469
GSM201837Muscle PCOS after pioglitazone 162164.12664
GSM201838Muscle PCOS after pioglitazone 202204.71470
GSM201839Muscle PCOS after pioglitazone 232225.45672
GSM201840Muscle PCOS after pioglitazone 252181.73264
GSM201841Muscle PCOS after pioglitazone 272178.8566
GSM201842Muscle PCOS after pioglitazone 32270.69382
GSM201843Muscle PCOS after pioglitazone 42219.87773
GSM201844Muscle PCOS after pioglitazone 82179.55663